Net Income Summary of Grifols, S.A.

Grifols, S.A.'s latest annual net income in 2023 was 59.31 Million EUR , down -71.52% from previous year.
Grifols, S.A.'s latest quarterly net income in 2024 Q1 was 21.41 Million EUR , down -61.75% from previous quarter.
Grifols, S.A. reported an annual net income of 208.27 Million EUR in 2022, down -21.5% from previous year.
Grifols, S.A. reported an annual net income of 265.32 Million EUR in 2021, down -57.1% from previous year.
Grifols, S.A. reported a quarterly net income of 14.84 Million EUR for 2024 Q2, down -30.71% from previous quarter.
Grifols, S.A. reported a quarterly net income of 60.03 Million EUR for 2023 Q2, up 666.53% from previous quarter.

Annual Net Income Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Net Income of Grifols, S.A. (2023 - 2005)

Year	Net Income	Net Income Growth
2023	59.31 Million EUR	-71.52%
2022	208.27 Million EUR	-21.5%
2021	265.32 Million EUR	-57.1%
2020	618.54 Million EUR	-1.06%
2019	625.14 Million EUR	4.78%
2018	596.64 Million EUR	-9.97%
2017	662.7 Million EUR	21.49%
2016	545.45 Million EUR	2.5%
2015	532.14 Million EUR	13.16%
2014	470.25 Million EUR	36.09%
2013	345.55 Million EUR	34.62%
2012	256.68 Million EUR	410.24%
2011	50.3 Million EUR	-56.45%
2010	115.51 Million EUR	-21.94%
2009	147.97 Million EUR	21.56%
2008	121.72 Million EUR	38.68%
2007	87.77 Million EUR	93.36%
2006	45.39 Million EUR	77.63%
2005	25.55 Million EUR	0.0%

Year	Net Income	Net Income Growth
2024 Q1	21.41 Million EUR	-61.75%
2024 Q2	14.84 Million EUR	-30.71%
2023 Q2	60.03 Million EUR	666.53%
2023 Q3	59.54 Million EUR	-0.82%
2023 FY	59.31 Million EUR	-71.52%
2023 Q1	-10.59 Million EUR	-152.8%
2023 Q4	55.99 Million EUR	-5.96%
2022 Q1	53.31 Million EUR	236.54%
2022 FY	208.27 Million EUR	-21.5%
2022 Q4	20.07 Million USD	-54.96%
2022 Q3	44.55 Million EUR	-50.68%
2022 Q2	90.33 Million EUR	69.46%
2021 Q1	129.93 Million EUR	-41.81%
2021 Q3	-39.04 Million EUR	-128.52%
2021 Q2	136.88 Million EUR	5.35%
2021 FY	265.32 Million EUR	-57.1%
2021 Q4	-39.04 Million USD	0.0%
2020 Q3	267.43 Million EUR	739.23%
2020 FY	618.54 Million EUR	-1.06%
2020 Q1	186.38 Million EUR	-7.62%
2020 Q2	31.86 Million EUR	-82.9%
2020 Q4	223.3 Million EUR	-16.5%
2019 Q2	172.5 Million EUR	50.84%
2019 Q4	201.74 Million EUR	47.77%
2019 FY	625.14 Million EUR	4.78%
2019 Q1	114.36 Million EUR	-10.89%
2019 Q3	136.52 Million EUR	-20.86%
2018 Q2	175.57 Million EUR	22.43%
2018 Q1	143.4 Million EUR	-37.9%
2018 FY	596.64 Million EUR	-9.97%
2018 Q3	149.31 Million EUR	-14.95%
2018 Q4	128.34 Million EUR	-14.05%
2017 FY	662.7 Million EUR	21.49%
2017 Q4	230.93 Million EUR	50.05%
2017 Q3	153.9 Million EUR	6.97%
2017 Q2	143.86 Million EUR	7.37%
2017 Q1	133.99 Million EUR	-3.85%
2016 Q1	125.24 Million EUR	-4.05%
2016 Q2	139.19 Million EUR	11.14%
2016 Q3	141.65 Million EUR	1.76%
2016 FY	545.45 Million EUR	2.5%
2016 Q4	139.36 Million EUR	-1.62%
2015 Q3	140.1 Million EUR	5.33%
2015 Q1	128.49 Million EUR	-2.12%
2015 FY	532.14 Million EUR	13.16%
2015 Q2	133.01 Million EUR	3.52%
2015 Q4	130.53 Million EUR	-6.83%
2014 Q4	131.26 Million EUR	15.0%
2014 FY	470.25 Million EUR	36.09%
2014 Q3	114.15 Million EUR	9.91%
2014 Q2	103.86 Million EUR	-14.14%
2014 Q1	120.97 Million EUR	54.08%
2013 Q4	78.51 Million EUR	-6.79%
2013 FY	345.55 Million EUR	34.62%
2013 Q1	91 Million EUR	53.35%
2013 Q2	91.79 Million EUR	0.87%
2013 Q3	84.23 Million EUR	-8.24%
2012 Q3	63.84 Million EUR	-3.21%
2012 Q2	65.96 Million EUR	-2.31%
2012 Q1	67.52 Million EUR	936.67%
2012 FY	256.68 Million EUR	410.24%
2012 Q4	59.34 Million EUR	-7.05%
2011 Q3	24.52 Million EUR	270.59%
2011 Q4	6.51 Million EUR	-73.44%
2011 FY	50.3 Million EUR	-56.45%
2011 Q1	33.64 Million EUR	81.94%
2011 Q2	-14.37 Million EUR	-142.73%
2010 FY	115.51 Million EUR	-21.94%
2010 Q4	18.49 Million EUR	-39.59%
2010 Q3	30.61 Million EUR	0.0%
2009 FY	147.97 Million EUR	21.56%
2008 FY	121.72 Million EUR	38.68%
2007 FY	87.77 Million EUR	93.36%
2006 FY	45.39 Million EUR	77.63%
2005 FY	25.55 Million EUR	0.0%

Peer Net Income Comparison of Grifols, S.A.

Name	Net Income	Net Income Difference
AstraZeneca PLC	5.95 Billion USD	99.004%
Bristol-Myers Squibb Company PFD CONV 2	8.02 Billion USD	99.261%
CSPC Pharmaceutical Group Limited	830.91 Million USD	92.861%
Clarus Therapeutics Holdings, Inc.	-56.51 Million USD	204.96%
Novartis AG	14.85 Billion USD	99.601%
PT Kalbe Farma Tbk.	179.7 Million USD	66.993%

Global Stocks Search

Grifols, S.A. (GIKLY)

Net Income Summary of Grifols, S.A.

Annual Net Income Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Net Income of Grifols, S.A. (2023 - 2005)

Peer Net Income Comparison of Grifols, S.A.